Recombinant human erythropoietin

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Cerebral PalsyNeurodevelopmentPoor Graft Function

23 competitors in Cerebral Palsy

#DrugCompanyPhaseTrials

1

Lioresal

Novartis

Approved

22

Naropin

FFresenius Kabi USA, LLC

Approved

33

Botox

VVitae Pharmaceuticals Inc., an Allergan affiliate

Approved

14

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

15

Valium

Akero Therapeutics

Approved

—6

Epsom Salt

FFresenius Kabi USA, LLC

Approved

—7

Ingrezza

Neurocrine Biosciences

Phase 3

18

Cyklokapron

JJ Molner

Phase 3

19

Ritalin

Novartis

Phase 1

110

Recombinant human erythropoietin

Amgen

Phase 3

1Show 10 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Erythropoietin5 trials

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Completed·Roche·Phase 3·NCT00144482·122 enrolled

Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?

Unknown status·RRigshospitalet, Denmark··NCT00265486·12 enrolled

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Completed·Roche·Phase 3·NCT00144495·104 enrolled

Show 2 more trials

Does Erythropoietin Improve Outcome in Very Preterm Infants?

Completed·SSwiss Neonatal Network·Phase 2·NCT00413946·420 enrolled

Identification of New Serum Markers for Detection of Abuse With Erythropoietin

Completed·UUniversity of Aarhus·N/A·NCT01320449·35 enrolled

Anemia4 trials

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy

Completed·Amgen·Phase 2·NCT00121030

A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .

Unknown status·AAngde Biotech Pharmaceutical Co., Ltd.·Phase 2·NCT05629598·150 enrolled

The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia

Unknown status·—·Phase 1·NCT03683810·50 enrolled

Show 1 more trial

Treatment for Patients Suffering From Anemia Due to Chemotherapy

Completed·Amgen·Phase 2·NCT00120692

Poor Graft Function2 trials

Decitabine for Poor Graft Function Post Allo-HSCT

Not yet recruiting·TThe First Affiliated Hospital of Soochow University·Phase 3·NCT05907499·76 enrolled

Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT

Not yet recruiting·TThe First Affiliated Hospital of Soochow University·Phase 3·NCT05669079·100 enrolled

Neuropathy2 trials

Traumatic Optic Neuropathy Treatment Trial (TONTT)

Completed·TTehran University of Medical Sciences·Phase 1/2·NCT01783847·117 enrolled

Traumatic Optic Neuropathy Treatment Trial 2

Completed·IIran University of Medical Sciences·Phase 3·NCT03308448·93 enrolled

Cerebral Palsy1 trial

Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy

Completed·—··NCT03303573·164 enrolled

13 more indications

Chronic Kidney Disease1 trial

Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease

Completed·RRufaida Mazahir·Phase 4·NCT04959578·50 enrolled

Non-Small Cell Lung Cancer1 trial

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

Completed·Amgen·Phase 2·NCT00120679

Sarcopenia1 trial

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

Not yet recruiting·TTianjin Medical University General Hospital·Phase 4·NCT07162090·60 enrolled

Amyotrophic Lateral Sclerosis1 trial

Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis

Unknown status·HHanyang University Seoul Hospital·Phase 1/2·NCT03835507·64 enrolled

Pregnancy1 trial

Intravenous Treatment of Anemia in Pregnancy

Completed·UUniversity of Zurich·Phase 4·NCT03317210·50 enrolled

Injury1 trial

Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants

Unknown status·UUniversity of Zurich·Phase 3·NCT02076373·120 enrolled

Lymphoma1 trial

Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma

Unknown status·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 3·NCT04910594·130 enrolled

Encephalopathy1 trial

Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy

Completed·ZZhengzhou University·Phase 1/2·NCT00808704·167 enrolled

Acute Kidney Injury1 trial

Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest

Completed·YYonsei University·Phase 4·NCT01369732·66 enrolled

Myelodysplastic Syndromes1 trial

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes

Completed·Bristol-Myers Squibb·Phase 1/2·NCT00910858·40 enrolled

Brain Injury1 trial

Effect of Erythropoietin on Preterm Brain Injury

Completed·—·Phase 4·NCT02036073·490 enrolled

Neurodevelopment1 trial

Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants

Unknown status·HHuiqing Sun·N/A·NCT02745990·440 enrolled

Unspecified1 trial

Tracing Changed Production of Red Blood Cells

Completed·UUniversity of Copenhagen·N/A·NCT05833477·12 enrolled

Details

Drug Info

Related News